Tennessee Oncology Pharmacists Association

Log in

General Information:

  • Only online registration is accepted.
  • Pharmacy residents and students are invited to attend free of charge. Please have your residency director or preceptor email us at tnoncpharm@gmail.com. 

Upcoming events

    • 04 Nov 2020
    • (UTC-05:00)
    • 14 Nov 2020
    • (UTC-05:00)
    • 4 sessions

    Please join us for our 5th Annual Meeting which will be offered as a series of virtual sessions, for a total of 9 hours of live continuing education credit!

Past events

26 Oct 2019 TOPA 4th Annual Meeting
29 Sep 2018 TOPA 3rd Annual Meeting
09 Sep 2017 TOPA 2nd Annual Meeting
24 Sep 2016 TOPA 1st Annual Meeting

TOPA 2020:

We are pleased to offer a virtual experience for our meeting this year and will be offering 9 hours of live CE over 4 virtual sessions.

The Board would like to thank our 2020 volunteers for their contributions to the annual meeting!

Hannah Alley

Renee McAlister

Jennifer Pauley

Alexander Quesenberry

Kendall Shultes

Gregory Sneed

Meeting Information:

TOPA 2020 Activity Announcement.pdf

The virtual sessions will be hosted on Zoom. Registrants will receive additional information and Zoom meeting link prior to each session. See this document for technology requirements and information on claiming CE.

Virtual sessions to be held on:

Wednesday, November 4 from 2-4 CST

  • Hemophilia Treatment: Factors to Consider
  • Pharmacogenomics in Oncology
  • Adapting to Payer Changes for Clinic-Administered Medications

Saturday, November 7 from 9-12 CST

  • GU Oncology: So Much to Know and So Little Time to Know It
  • New Drug Update
  • New Developments in the Management of HER2+ and Triple-Negative Breast Cancer

Wednesday, November 11 from 2-4 CST

  • Impact of COVID-19 on Oncology Care
  • Updates in Thoracic Oncology
  • Nucleic Acid-Based Diagnostic Techniques in Malignancy

Saturday, November 14 from 9-11 CST

  • The Art of Giving Feedback: How to Give Feedback that Improves Performance
  • Eyes on the Target: Updates in the Treatment of Chronic Lymphocytic Leukemia
  • New Options for Relapsed & Refractory Osteosarcoma



Powered by Wild Apricot Membership Software